Cannabis

Global spending on legal cannabis is expected to grow 230% to $31.3% billion in 2022 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. The research projects a majority of that, nearly $23.4 billion will come from the United States. In context of more states voting in favor of marijuana use legalization and business interest sparking across the board, that definitely would make sense.

In the year through January 11, 2019, the United States Marijuana Index, fell 20.7%, as compared to about 6.5% loss seen by the S&P 500. Given that is not exactly an apples to apples comparison, but it does make a case to at least investigate investments in marijuana stocks. (May 6, 2019, Mrinalini Krishna, Investopedia)

Canadian cannabis companies were expecting to capitalize on opportunities such as legalization of derivatives but it seems the COVID-19 pandemic will derail those opportunities. However, although there have been delays in the launch of derivatives and the opening of more stores the industry has benefitted from a surge in...
The coronavirus pandemic has hit the world hard and it is affecting every sector including the cannabis industry. Cannabis operators have to contend with this new reality which has disrupted the industry in various ways. The pandemic has worsened the situation for an industry that has been battling problems...
Coronavirus pandemic has swept across over 200 countries and its economic impact is felt in various sectors the cannabis industry included. The cannabis industry has been facing challenges in the past year but the COVID-19 pandemic has just turned it into a dumpster fire. Although the pandemic has affected...
Following the coronavirus outbreak, various countries have imposed measures such as locking all non-essential businesses and restricting the movement of people to combat spread. However, for the Canadian cannabis business, they are still operating as usual as the government considers them essential services. Most of the Canadian governments have...
The coronavirus pandemic has triggered one of the biggest market crash in recent history.  Stock market indices are already down by more than 20% and officially in bear territory. Amidst growing concerns about the global economic recession, investments in the stock markets are slowly drying up.  As bleak things...
The coronavirus pandemic has triggered one of the biggest corrections in the equity markets in recent history. With the correction, so are a number of investment opportunities cropping up especially in the burgeoning Canadian cannabis industry that continues to experience an increase in sales. MediPharm Labs Corp (TSE: LABS),...
The Canadian cannabis industry had a terrible 2019 where most cannabis operators burnt significant investor wealth. Over the past few weeks, the coronavirus outbreak has affected markets and cannabis stocks have not been spared either. Although the impact the pandemic might have on revenues of cannabis operators is debatable...
The impact of the coronavirus outbreak and the falling of global oil prices has had a major impact on Canadian Cannabis stocks. Stocks of companies such as Tilray Inc. (NASDAQ: TLRY), Aurora Cannabis (NYSE: ACB), Canopy Growth Corp (NYSE: CGC) and Cronos Group (NASDAQ: CRON) all dropped 8.3%, 7.7%,...
In 2018 when Canada legalized recreational use cannabis there was a lot of optimism on the potential of the industry. However last year the industry sales fell short of expectations but going to 2020 the industry is poised to pick up growth momentum again. Despite the industry grappling with...
There is a lot of potential in the cannabis industry, and according to analysts, it could soon give investors good returns.  In the past few years, global cannabis sales have increased significantly, but the industry is still grappling with some issues. In Canada, for instance, cannabis operators have been...